Faeth Therapeutics, Inc.
FTH· Nasdaq
Released May 9, 2024, before the open
10-Q filed May 9, 2024, 39 days after period end · 0000950170-24-057106
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$7.99M | -$10.18M | -$12.41M | -$7.97M |
| EPS Diluted | -$0.32 | -$0.33 | -$0.40 | -$0.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Faeth Therapeutics, Inc. · CIK 1829802 · Engraved from SEC EDGAR